Acasă

Machine learning reveals why cancer trials fall short in real-world patients

Adrian Bogdan

By Dr. Liji Thomas, MD Reviewed by Lily Ramsey, LLM Jan 10 2025 TrialTranslator uncovers the survival gap for high-risk patients and offers a path to better cancer research. Study:  Evaluating generalizability of oncology trial results to real-world patients using machine learning-based trial emulations . Image Credit: Komsan Loonprom/Shutterstock.com Many cancer trial results don’t generalize well to real-world patients. A research team explored this issue with TrialTranslator, a machine-

din zilele anterioare

Machine learning reveals why cancer trials fall short in real-world patients https://www.news-medical.net - 10.01.2025 16:27
STIRILE OREI
IN FOCUS: ‘When I die, who’s going to look after you?’ – the pains of caring for adults with disabilities https://www.channelnewsasia.com/ - 06:00
IN FOCUS: ‘When I die, who’s going to look after you?’ – the pains of caring for adults with disabilities https://www.channelnewsasia.com - 06:00
IN FOCUS: ‘I only wish to live one second longer’ – the pains of parents of adults with disabilities https://www.channelnewsasia.com/ - 06:00
IN FOCUS: ‘I only wish to live one second longer’ – the pains of parents of adults with disabilities https://www.channelnewsasia.com - 06:00
Commentary: After a poor run in 2024, politics around the world needs to change fundamentally. Here's how https://www.channelnewsasia.com - 06:00
© Copyright 2017 Mediafax SA | Termeni și condiţii | About cookies | Confidentialitate

monitoruldestiri@mediafax.ro

Fotografiile folosite de monitoruldestiri.ro sunt proprietatea Mediafax. Este interzisă republicarea acestora în lipsa unui acord din partea Mediafax. Pentru a obține acest acord, vă rugăm să ne contactați.